KR20180055120A - Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same - Google Patents
Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same Download PDFInfo
- Publication number
- KR20180055120A KR20180055120A KR1020160152535A KR20160152535A KR20180055120A KR 20180055120 A KR20180055120 A KR 20180055120A KR 1020160152535 A KR1020160152535 A KR 1020160152535A KR 20160152535 A KR20160152535 A KR 20160152535A KR 20180055120 A KR20180055120 A KR 20180055120A
- Authority
- KR
- South Korea
- Prior art keywords
- protein
- brown
- protein hydrolyzate
- hydrolyzate
- larvae
- Prior art date
Links
- 239000003531 protein hydrolysate Substances 0.000 title claims abstract description 68
- 241000254109 Tenebrio molitor Species 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 title claims description 12
- 108010009736 Protein Hydrolysates Proteins 0.000 title abstract description 12
- 235000013305 food Nutrition 0.000 title description 13
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 31
- 239000000203 mixture Substances 0.000 claims abstract description 28
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 27
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 23
- 235000013376 functional food Nutrition 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims description 44
- 108090000623 proteins and genes Proteins 0.000 claims description 44
- 229940088598 enzyme Drugs 0.000 claims description 43
- 102000004190 Enzymes Human genes 0.000 claims description 38
- 108090000790 Enzymes Proteins 0.000 claims description 38
- 230000003301 hydrolyzing effect Effects 0.000 claims description 25
- 239000000243 solution Substances 0.000 claims description 23
- 239000000758 substrate Substances 0.000 claims description 22
- 102000005158 Subtilisins Human genes 0.000 claims description 14
- 108010056079 Subtilisins Proteins 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- 241000283707 Capra Species 0.000 claims description 10
- 102000057297 Pepsin A Human genes 0.000 claims description 10
- 108090000284 Pepsin A Proteins 0.000 claims description 10
- 229940111202 pepsin Drugs 0.000 claims description 10
- 239000000843 powder Substances 0.000 claims description 9
- 241000218652 Larix Species 0.000 claims description 8
- 235000005590 Larix decidua Nutrition 0.000 claims description 8
- 108010019160 Pancreatin Proteins 0.000 claims description 7
- 108090000787 Subtilisin Proteins 0.000 claims description 7
- 238000010438 heat treatment Methods 0.000 claims description 7
- 108010009355 microbial metalloproteinases Proteins 0.000 claims description 7
- 229940055695 pancreatin Drugs 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- 241000272525 Anas platyrhynchos Species 0.000 claims description 6
- 239000007853 buffer solution Substances 0.000 claims description 6
- 230000001418 larval effect Effects 0.000 claims description 6
- 108010007119 flavourzyme Proteins 0.000 claims description 5
- 239000012528 membrane Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 210000004185 liver Anatomy 0.000 claims description 4
- 239000011259 mixed solution Substances 0.000 claims description 4
- 230000003064 anti-oxidating effect Effects 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 230000002797 proteolythic effect Effects 0.000 claims description 3
- 230000009467 reduction Effects 0.000 claims description 3
- 102000035195 Peptidases Human genes 0.000 claims description 2
- 108091005804 Peptidases Proteins 0.000 claims description 2
- 241000219122 Cucurbita Species 0.000 claims 1
- 235000009852 Cucurbita pepo Nutrition 0.000 claims 1
- 235000019833 protease Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 238000004519 manufacturing process Methods 0.000 abstract description 5
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000002443 hepatoprotective effect Effects 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 description 39
- 239000004365 Protease Substances 0.000 description 12
- 239000003963 antioxidant agent Substances 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 12
- 238000002835 absorbance Methods 0.000 description 11
- OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 11
- 230000002292 Radical scavenging effect Effects 0.000 description 10
- 210000004027 cell Anatomy 0.000 description 10
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000005259 measurement Methods 0.000 description 9
- 241000238631 Hexapoda Species 0.000 description 8
- 238000007254 oxidation reaction Methods 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 7
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 7
- 108091005658 Basic proteases Proteins 0.000 description 6
- 108010004032 Bromelains Proteins 0.000 description 6
- 108090000526 Papain Proteins 0.000 description 6
- -1 aromatic amino acid Chemical class 0.000 description 6
- 235000019835 bromelain Nutrition 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 230000003647 oxidation Effects 0.000 description 6
- 229940055729 papain Drugs 0.000 description 6
- 235000019834 papain Nutrition 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 230000002000 scavenging effect Effects 0.000 description 6
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 210000003494 hepatocyte Anatomy 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000013373 food additive Nutrition 0.000 description 4
- 239000002778 food additive Substances 0.000 description 4
- 235000016709 nutrition Nutrition 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 230000002633 protecting effect Effects 0.000 description 4
- 239000012064 sodium phosphate buffer Substances 0.000 description 4
- 230000035882 stress Effects 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- RVBUGGBMJDPOST-UHFFFAOYSA-N 2-thiobarbituric acid Chemical compound O=C1CC(=O)NC(=S)N1 RVBUGGBMJDPOST-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000272814 Anser sp. Species 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 3
- 235000020778 linoleic acid Nutrition 0.000 description 3
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000002953 phosphate buffered saline Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 239000012588 trypsin Substances 0.000 description 3
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 3
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 3
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 2
- 241001444063 Aronia Species 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000382353 Pupa Species 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- BGNXCDMCOKJUMV-UHFFFAOYSA-N Tert-Butylhydroquinone Chemical compound CC(C)(C)C1=CC(O)=CC=C1O BGNXCDMCOKJUMV-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 239000000469 ethanolic extract Substances 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 2
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- 229910052711 selenium Inorganic materials 0.000 description 2
- 239000011669 selenium Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 239000004250 tert-Butylhydroquinone Substances 0.000 description 2
- 235000019281 tert-butylhydroquinone Nutrition 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 description 1
- WCBPJVKVIMMEQC-UHFFFAOYSA-N 1,1-diphenyl-2-(2,4,6-trinitrophenyl)hydrazine Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1NN(C=1C=CC=CC=1)C1=CC=CC=C1 WCBPJVKVIMMEQC-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XRCRJFOGPCJKPF-UHFFFAOYSA-N 2-butylbenzene-1,4-diol Chemical compound CCCCC1=CC(O)=CC=C1O XRCRJFOGPCJKPF-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 241000762358 Anomala albopilosa Species 0.000 description 1
- 102000044503 Antimicrobial Peptides Human genes 0.000 description 1
- 108700042778 Antimicrobial Peptides Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 description 1
- 241001529599 Colaspis brunnea Species 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010058359 Hypogonadism Diseases 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical compound O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 description 1
- 241000034039 Manouria emys Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 101001026869 Mus musculus F-box/LRR-repeat protein 3 Proteins 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 244000171263 Ribes grossularia Species 0.000 description 1
- 235000002357 Ribes grossularia Nutrition 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 230000006907 apoptotic process Effects 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 235000020739 avocado extract Nutrition 0.000 description 1
- XYOVOXDWRFGKEX-UHFFFAOYSA-N azepine Chemical compound N1C=CC=CC=C1 XYOVOXDWRFGKEX-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 235000013985 cinnamic acid Nutrition 0.000 description 1
- 229930016911 cinnamic acid Natural products 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 231100000433 cytotoxic Toxicity 0.000 description 1
- 230000001472 cytotoxic effect Effects 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003957 dexamethasone Drugs 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000012470 diluted sample Substances 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000007515 enzymatic degradation Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 229960002089 ferrous chloride Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 238000007306 functionalization reaction Methods 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012812 general test Methods 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- NMCUIPGRVMDVDB-UHFFFAOYSA-L iron dichloride Chemical compound Cl[Fe]Cl NMCUIPGRVMDVDB-UHFFFAOYSA-L 0.000 description 1
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 150000002926 oxygen Chemical class 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 210000002824 peroxisome Anatomy 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 239000003910 polypeptide antibiotic agent Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 235000021067 refined food Nutrition 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 229940083575 sodium dodecyl sulfate Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- DAJSVUQLFFJUSX-UHFFFAOYSA-M sodium;dodecane-1-sulfonate Chemical compound [Na+].CCCCCCCCCCCCS([O-])(=O)=O DAJSVUQLFFJUSX-UHFFFAOYSA-M 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/31—Foods, ingredients or supplements having a functional effect on health having an effect on comfort perception and well-being
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/204—Animal extracts
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
Description
본 발명은 갈색거저리 유충의 단백 가수분해물, 이의 제조방법 및 이를 포함하는 기능성 식품 조성물에 관한 것이다.The present invention relates to a protein hydrolyzate of brown larch, a method for producing the protein hydrolyzate, and a functional food composition containing the same.
최근 국제식량농업기구(FAO)에서는 질병이나 환경오염으로 인한 식량부족 문제를 해결하기 위한 정책으로 미래 식량자원으로서의 식용곤충의 활성화방안을 발표한 바 있고, 이에 대한 관심이 전 세계적으로 증대되고 있다. 이와 발맞추어 국내에서는 농림수산식품부가 "곤충산업육성 5개년 종합계획"을 발표하였고, 그에 따라 곤충 산업에 대한 지원이 이루어져 왔다.Recently, the FAO has announced plans to revitalize edible insects as a future food resource as a policy to solve the food shortage problem caused by diseases and environmental pollution, and interest in this is increasing worldwide. In line with this, the Ministry of Food, Agriculture, Forestry and Fisheries has announced the "Five-Year Comprehensive Plan for Insect Industry Development" and has been supporting the insect industry accordingly.
곤충은 약 100만 종 이상 보고되었음에도 100만 종 이상이 아직 보고되지 않은 상태로 남아있다고 예측될 정도로 지구상에서 가장 다양성이 풍부한 종이다. 예로부터 곤충은 약용으로 사용해 왔으며, 그 중 누에, 메뚜기, 굼벵이, 지네 등은 당뇨, 염증성 질환, 간질환 및 동맥경화 등의 만성 질환 치료에 효과적이라는 연구결과가 보고되었다.Insects are the most diverse species on the planet, with more than one million species reported, but more than one million species are expected to remain unreported. Insects have been used as medicines for some time, and silkworms, grasshoppers and zines have been reported to be effective in the treatment of chronic diseases such as diabetes, inflammatory diseases, liver diseases and arteriosclerosis.
갈색거저리(Tenebrio molitor , mealworm)는 딱정벌레목 거저리과의 곤충으로 "갈색쌀거저리"라고도 불리며 현재 한국을 비롯한 전 세계에 분포되어 있고, 강한 적응력을 가지고 있으며 변태 기간이 짧아 쉬운 사육기술로도 연중 사육이 가능하여 산업화에 용이하다. 또한, 갈색거저리의 영양성분은 수분이 2.90%, 조단백질이 50.32%, 조지방 33.70%, 조회분 3.76%, 조섬유 4.81%로, 매우 높은 영양성분들을 가지고 있다. 이와 관련하여, 갈색거저리가 단백질 함량이 매우 높은 고단백질 소재로 2016년 식용곤충원료로 식품공전에 등록됨으로써 갈색거저리의 활용에 대한 관심이 높아지고 있다. 갈색거저리 유충은 대두보다 필수 아미노산을 많이 함유하고 있고, 육류에 비해 불포화 지방산 함량이 높으며, 비타민 A와 철, 식이섬유 등이 비교적 풍부한 편으로 영양적인 장점이 많다. 더욱이, 가축 사육과는 달리 곤충 사육에 필요한 땅을 개선할 필요가 없고, 적은 사료만으로도 간편하게 많은 양의 곤충을 사육하여 보급할 수 있으므로 경제적 부담이 적은 장점도 있다.Brown Tortoise ( Tenebrio molitor , mealworm) is an insect of beetle, and it is called "brown rice duck". It is distributed in Korea and other parts of the world. It has a strong adaptability and it has a short transfiguration period. It is easy. In addition, nutritional components of brown goat have very high nutritional content, such as 2.90% moisture, 50.32% crude protein, 33.70% crude fat, 3.76% inquiry and 4.81% crude fiber. In relation to this, brown dough is a high-protein material with a very high protein content and is registered as a food source for food insecticides in 2016, thereby increasing interest in the use of brown dough. Brown goat larvae contain more essential amino acids than soybeans, have higher unsaturated fatty acid content than meat, and are rich in vitamin A, iron, and dietary fiber. Moreover, unlike livestock breeding, there is no need to improve the land required for insect rearing, and it is possible to easily feed large amounts of insects with only a small amount of feed, which is economical.
국내에서 이루어진 갈색거저리 유충에 관한 연구로는 갈색거저리 유충 추출물의 간암세포에 대한 세포 독성효능, 갈색거저리 에탄올 추출물의 멜라닌 생성 저해 효과 등 갈색거저리 추출물을 이용한 연구들을 들 수 있는데, 이와 달리 갈색거저리 유충의 생리활성 펩타이드에 대한 연구는 부족한 실정이다.Studies on the brown goose larvae in Korea include studies on the cytotoxic effect of the brown goose larvae extract on hepatocarcinoma cells and the inhibition of melanin formation of the brown goose-ethanol extracts. In contrast, brown gooseberry larvae The research on physiologically active peptides is in short supply.
생리활성 펩타이드는 일반적으로 생리적 활성을 가지는 분자량이 작은 펩타이드로 정의되며, 보통 3-20개의 아미노산으로 구성되고 아미노산의 조성이나 서열에 따라 그 활성이 다양하다. 또한, 크기가 작아 생체 내로 쉽게 흡수될 수 있으며, 다양한 기능적 특성을 나타낸다. 지금까지 연구된 생리활성 펩타이드의 효과로는 우유 단백질 가수분해물의 체내 항산화 기능 향상과 가공 식품에서의 산화 반응 방지, 달걀흰자 가수분해물의 새로운 항균 펩타이드 등이 있으며, 그 외에도 항 고혈압, 항 혈전, 면역 조절 등의 생리활성 펩타이드의 기능성 연구가 활발하게 진행되고 있다. Physiologically active peptides are generally defined as peptides with small molecular weight with physiological activity. They are usually composed of 3-20 amino acids, and their activities vary depending on the composition and sequence of amino acids. In addition, it is small in size and can be easily absorbed into living body, and exhibits various functional properties. The effects of the physiologically active peptides studied so far include improvement of the antioxidant function of the milk protein hydrolyzate, prevention of the oxidation reaction in the processed food, and a new antimicrobial peptide of the egg white hydrolyzate. In addition, antihypertensive, antithrombotic, And the like have been actively studied for the functionalization of physiologically active peptides.
한편, 항산화제란 산화에 의해서 일어나는 식품의 냄새나 풍미의 변화, 유지의 산패, 식품의 변색을 방지하거나 지연할 수 있는 기능을 가진 화합물을 총칭하며 인공합성물을 비롯하여 동식물체 내에도 이런 기능을 갖는 물질이 많이 알려졌다. 이렇듯 산화 반응을 억제할 수 있는 항산화제에 대한 관심이 증대되면서 다양한 합성 항산화제인 뷰틸레이티드 하이드록시톨루엔(butylated hydroxytoluene; BHT), 뷰틸레이티드 히드록시아니솔(butylated hydroxyanisole; BHA), 뷰틸하이드로퀴논(tert-butylhydroquinone; TBHQ) 등이 널리 이용되고 있다.On the other hand, antioxidants are compounds that have the function of preventing or delaying the change of the smell and flavor of food caused by oxidation, the rancidity of the fattening and the discoloration of the food, and also the artificial compounds, Much of the material is known. As the interest in antioxidants that can suppress the oxidation reaction has increased, various synthetic antioxidants such as butylated hydroxytoluene (BHT), butylated hydroxyanisole (BHA), butyl hydroquinone and tert-butylhydroquinone (TBHQ).
그러나 이러한 합성 항산화제들의 안전성 논란이 꾸준히 제기되어 허용량에 대한 법적 규제가 엄격한 바, 이를 대체하기 위하여 상대적으로 안전한 천연 항산화제에 대한 연구가 활발하게 이루어지는 중이다.However, since the safety controversy of these synthetic antioxidants has been constantly raised, legal restrictions on the amount of the antioxidants have been strictly regulated. As a result, studies on natural antioxidants that are relatively safe have been actively conducted to replace them.
이에, 전술한 바와 같이, 갈색거저리 유충은 사육이 용이하고 매우 많은 영양소들을 가지고 있으므로 대량 생산이 가능하며 천연 항산화제로 이용할 수 있는, 갈색거저리 유충에서 획득한 생리활성 펩타이드 획득을 위한 기술 개발 및 이를 이용한 새로운 천연 항산화제 개발이 필요한 실정이다.Thus, as described above, the development of a technique for obtaining a physiologically active peptide obtained from a brown goat larva, which can be mass-produced and used as a natural antioxidant, is easy to breed and has a great number of nutrients. It is necessary to develop new natural antioxidants.
본 발명의 목적은 항산화 효과가 뛰어난 단백 가수분해물을 제공하는 것이다.An object of the present invention is to provide a protein hydrolyzate excellent in antioxidant effect.
본 발명의 다른 목적은 항산화 효과가 뛰어나 다양하게 활용 가능한 기능성 식품 조성물을 제공하는 것이다.Another object of the present invention is to provide a functional food composition which is excellent in antioxidative effect and can be utilized in various ways.
본 발명의 또 다른 목적은 항산화 효과가 뛰어난 단백 가수분해물의 제조방법을 제공하는 것이다.It is still another object of the present invention to provide a method for producing a protein hydrolyzate having an excellent antioxidative effect.
상기 목적을 달성하기 위하여 본 발명은, 단백질 가수분해효소인 알칼라아제(Alcalase)로 가수분해된 갈색거저리( Tenebrio molitor , mealworm) 유충의 단백 가수분해물 또는 플라보르자임(Flavourzyme), 뉴트라아제(Neutrase), 펩신(Pepsin), 서브틸리신(Subtilisin) 및 판크레아틴(Pancreatin)으로 이루어진 군에서 선택되는 하나 이상의 단백질 가수분해효소와 알칼라아제(Alcalase)로 가수분해된 갈색거저리(Tenebrio molitor, mealworm) 유충의 단백 가수분해물을 제공한다. The present invention to achieve the above object, proteolytic enzyme, Alcala dehydratase (Alcalase) the hydrolysis to mealworm (Tenebrio molitor , mealworm) or a protein hydrolyzate of at least one protein selected from the group consisting of Flavourzyme, Neutrase, Pepsin, Subtilisin and Pancreatin. It provides proteolytic hydrolysates of larvae ( Tenebrio molitor, mealworm) hydrolyzed with degrading enzymes and alkalase.
상기 다른 목적을 달성하기 위하여 본 발명은, 상기 갈색거저리 유충의 단백 가수분해물을 포함하는 항산화용 기능성 식품 조성물, 간 보호용 기능성 식품 조성물 또는 스트레스 감소용 기능성 식품 조성물을 제공한다.In order to accomplish the above other objects, the present invention provides a functional food composition for antioxidation, a functional food composition for liver protection or a functional food composition for stress reduction, which comprises the protein hydrolyzate of the brown larch larva.
상기 또 다른 목적을 달성하기 위하여 본 발명은, (a) 기질인 건조된 갈색거저리( Tenebrio molitor, mealworm) 유충의 분말을 물 또는 완충용액에 1 내지 10%(w/v)로 혼합하여 기질 용액을 제조하는 단계; (b) 상기 기질 용액을 가열하여 기질 용액에 포함된 자가 효소를 불활성화하는 단계; (c) 상기 기질 용액에 단백질 가수분해 효소를 갈색거저리 유충 분말 대비 0.1 내지 5%(w/v)가 되도록 혼합하여 혼합액을 제조하는 단계; (d) 상기 혼합액에서 단백질 가수분해 효소와 갈색거저리 유충 분말을 반응시켜 반응 혼합액을 제조하는 단계; (e) 상기 반응 혼합액을 가열함으로써 단백질 가수분해 효소를 불활성화시켜 반응이 완료된 혼합액을 얻는 단계; (f) 상기 단계 (e)에서 얻어진 혼합액을 원심분리하여 상등액을 취하는 단계; (g) 상기 상등액을 여과막을 이용하여 원심분리하는 단계; 및 (h) 중량 평균 분자량이 0.01 kDa 이상 3 kDa 이하인 단백 가수분해물을 분리하는 단계;를 포함하는 갈색거저리 유충의 단백 가수분해물 제조방법을 제공한다.The addition the present invention to another aspect is, (a) the substrate is dried mealworm (Tenebrio molitor, mealworm) and mixed with a powder of the larvae in water or a buffer solution from 1 to 10% (w / v) substrate solution Lt; / RTI > (b) heating the substrate solution to inactivate the self-enzyme contained in the substrate solution; (c) mixing the substrate solution with a protein hydrolyzing enzyme in an amount of 0.1 to 5% (w / v) relative to the brown goat larvae powder to prepare a mixture; (d) preparing a reaction mixture by reacting a protein hydrolyzing enzyme and a brown larvae larva in the mixture; (e) heating the reaction mixture to inactivate the protein hydrolyzing enzyme to obtain a reaction mixture; (f) centrifuging the mixed solution obtained in step (e) to take a supernatant; (g) centrifuging the supernatant using a filtration membrane; And (h) separating a protein hydrolyzate having a weight average molecular weight of 0.01 kDa or more and 3 kDa or less.
본 발명의 갈색거저리 유충 단백 가수분해물은 특정 효소를 사용함으로써 3 kDa 이하의 생리활성 펩타이드를 포함하여 항산화 효과가 매우 뛰어나므로, 상기 단백 가수분해물을 포함하는 기능성 식품 조성물은 스트레스를 감소시키거나, 활성 산소로부터 간 세포를 보호하여 활성 산소와 관련이 있는 질환을 예방 또는 개선하는 데에 유용하게 활용될 수 있다.Since the brown gill larva protein hydrolyzate of the present invention contains a physiologically active peptide having a bioactive peptide of 3 kDa or less by using a specific enzyme, the functional food composition containing the protein hydrolyzate can reduce stress, It can be usefully used for protecting liver cells from oxygen to prevent or improve diseases associated with active oxygen.
도 1은 본 발명의 하나의 실시예에 따른 갈색거저리 유충 단백질 가수분해물을 제조하는 방법을 모식도로 표현한 것이다.
도 2는 본 발명의 다른 하나의 실시예에 따른 갈색거저리 유충 단백질 가수분해물의 SDS-PAGE 실험 결과이다.
도 3은 도 2의 실시예에 따른 갈색거저리 유충 단백질 가수분해물의 수율을 측정한 것이다.
도 4는 도 2의 실시예에 따른 갈색거저리 유충 단백질 가수분해물의 단백질 가수분해도를 측정한 것이다.
도 5는 본 발명의 또 다른 하나의 실시예에 따른 갈색거저리 유충 단백질 가수분해물에서, 생리활성 펩타이드들의 DPPH 라디칼 소거활성을 측정한 결과이다.
도 6은 도 5의 실시예에 따른 갈색거저리 유충 단백질 가수분해물에서, 생리활성 펩타이드들의 ABTS 라디칼 소거활성을 측정한 결과이다.
도 7은 도 5의 실시예에 따른 갈색거저리 유충 단백질의 가수분해물에서, 생리활성 펩타이드들의 과산화수소 소거활성을 측정한 결과이다.
도 8은 도 5의 실시예에 따른 갈색거저리 유충 단백질의 가수분해물에서, 생리활성 펩타이드들의 리놀레산 산화 방지 효과를 확인한 결과이다.
도 9는 본 발명의 또 다른 하나의 실시예에 따른 갈색거저리 유충 단백질 가수분해물의 간 세포 보호 효과를 확인한 결과이다.BRIEF DESCRIPTION OF THE DRAWINGS FIG. 1 is a schematic diagram illustrating a method of preparing a brown gill larva protein hydrolyzate according to one embodiment of the present invention.
FIG. 2 is a result of SDS-PAGE of the brown larvae protein hydrolyzate according to another embodiment of the present invention.
FIG. 3 is a graph showing the yield of the brown gill larva protein hydrolyzate according to the embodiment of FIG. 2. FIG.
FIG. 4 is a graph showing the degree of protein hydrolysis of the brown gill larva protein hydrolyzate according to the embodiment of FIG. 2. FIG.
FIG. 5 is a graph showing DPPH radical scavenging activity of physiologically active peptides in the brown gill larva protein hydrolyzate according to another embodiment of the present invention.
FIG. 6 is a graph showing the results of measuring the ABTS radical scavenging activity of physiologically active peptides in the brown gill larva protein hydrolyzate according to the embodiment of FIG. 5. FIG.
FIG. 7 shows the results of measurement of the hydrogen peroxide scavenging activity of the physiologically active peptides in the hydrolysates of the larvae of the larvae according to the embodiment of FIG.
FIG. 8 shows the results of confirming the effect of inhibiting linoleic acid oxidation of physiologically active peptides in the hydrolysates of the larvae of the larvae according to the embodiment of FIG.
FIG. 9 shows the results of confirming the hepatocyte protective effect of the brown gill larva protein hydrolyzate according to another embodiment of the present invention.
이하, 본 발명을 보다 자세히 설명한다.Hereinafter, the present invention will be described in more detail.
본 발명은 단백질 가수분해효소인 알칼라아제(Alcalase)로 가수분해된 갈색거저리( Tenebrio molitor, mealworm) 유충의 단백 가수분해물을 제공한다. The present invention provides a protein hydrolyzate of a larva ( Tenebrio molitor, mealworm) hydrolyzed with a protein hydrolyzing enzyme, Alcalase.
본 발명에서 "알칼라아제(Alcalase)"는 박테리아나 진균에서 생성되는 단백질 가수분해 효소로, pH 7-9 부근의 조건에서 강한 단백질 분해능을 나타낼 수 있다.In the present invention, "Alcalase" is a protein hydrolyzing enzyme produced from bacteria or fungi, and can exhibit strong protein resolution under the condition of about pH 7-9.
본 발명의 일 실시예에서 상기 알칼라아제로 가수분해된 갈색거저리 유충의 단백 가수분해물은 매우 높은 항산화 효과 및 활성산소로부터의 간세포 보호 효과를 나타낸 바, 상기 단백 가수분해물은 다양한 기능성 식품으로 유용하게 활용될 수 있다.In one embodiment of the present invention, the protein hydrolyzate of the larvae hydrolyzed with the alkaline protease exhibits a very high antioxidative effect and the effect of protecting the hepatocyte from the active oxygen, and the protein hydrolyzate is useful as various functional foods Can be utilized.
또한, 본 발명은 플라보르자임(Flavourzyme), 뉴트라아제(Neutrase), 펩신(Pepsin), 서브틸리신(Subtilisin) 및 판크레아틴(Pancreatin)으로 이루어진 군에서 선택되는 하나 이상의 단백질 가수분해효소와 알칼라아제(Alcalase)로 가수분해된 갈색거저리(Tenebrio molitor , mealworm) 유충의 단백 가수분해물을 제공하며, 이때, 상기 단백질 가수분해효소들은 플라보르자임, 뉴트라아제, 펩신, 서브틸리신 및 판크레아틴에 제한되지는 않는다.The present invention also relates to a pharmaceutical composition comprising at least one protein hydrolyzing enzyme selected from the group consisting of Flavourzyme, Neutrase, Pepsin, Subtilisin and Pancreatin, A brown goose hydrolyzed with Alcalase ( Tenebrio molitor , and mealworm) protein hydrolysates, wherein the protein hydrolytic enzymes are not limited to flavorzyme, ntrease, pepsin, subtilisin, and pancreatin.
본 발명에서 "플라보르자임(Flavourzyme)"은 진균류에서 얻을 수 있는 단백질 가수분해 효소로, pH 6-7 부근의 조건에서 단백질 분해능을 나타낼 수 있다.In the present invention, "flavorzyme" is a protein hydrolyzing enzyme obtainable from fungi, and can exhibit protein resolution at a pH of about 6-7.
본 발명에서 "뉴트라아제(Neutrase)"는 바실러스 균에서 얻을 수 있는 단백질 가수분해 효소로, pH 5.5-7.5 부근의 조건에서 단백질 내부의 펩타이드 본드를 가수분해함으로써 단백질 분해능을 나타낼 수 있다.In the present invention, "Neutrase" is a protein hydrolyzing enzyme obtainable from Bacillus subtilis, and can exhibit proteolytic activity by hydrolyzing a peptide bond inside the protein at a pH of about 5.5 to 7.5.
본 발명에서 “펩신(Pepsin)”은 동물의 위(stomach)의 주세포(chief cell)에서 분비되는 단백질 가수분해 효소로, 단백질에서 페닐알라닌과 타이로신과 같은 방향족 아미노산이 있는 부분을 가수분해할 수 있다.In the present invention, " pepsin " is a protein hydrolyzing enzyme secreted in the stomach chief cell of an animal. The protein hydrolyzing enzyme can hydrolyze a portion of the protein having an aromatic amino acid such as phenylalanine and tyrosine.
본 발명에서 “서브틸리신(Subtilisin)”은 바실러스 균에서 얻을 수 있는 세린 단백질 가수분해효소로, 중성에서 알칼리성 정도의 최적 활성 pH를 가진다.In the present invention, " Subtilisin " is a serine protease, which can be obtained from Bacillus sp., And has an optimal active pH of about neutral to alkaline.
본 발명에서 “판크레아틴(Pancreatin)”은 동물의 췌장에서 만들어지는 단백질 가수분해 효소로, 대략 pH 8.0 전후에서 단백질 분해능을 나타낼 수 있다. In the present invention, " pancreatin " is a protein hydrolyzing enzyme produced in the pancreas of an animal and can exhibit protein resolution around pH 8.0.
이때, 상기 단백 가수분해물은 0.01 kDa 이상 3 kDa 이하의 펩타이드를 포함할 수 있으며, 상기 펩타이드는 생리활성 펩타이드로도 불릴 수 있다.At this time, the protein hydrolyzate may include peptides of 0.01 kDa or more and 3 kDa or less, and the peptides may be also referred to as physiologically active peptides.
이와 같이, 상기 생리활성 펩타이드를 포함하고 있는 상기 단백 가수분해물은 항산화 효과를 나타낼 수 있다.Thus, the protein hydrolysates containing the physiologically active peptides can exhibit an antioxidative effect.
더욱이, 본 발명은 상기 갈색거저리 유충의 단백 가수분해물을 포함하는 항산화용 기능성 식품 조성물 또는 간 보호용 기능성 식품 조성물 또는 스트레스 감소용 기능성 식품 조성물을 제공한다.Furthermore, the present invention provides a functional food composition for antioxidation or a functional food composition for liver protection or a functional food composition for stress reduction comprising the protein hydrolyzate of brown larch larva.
즉, 상기 단백 가수분해물이 생리활성 펩타이드를 포함하고 있으므로, 이를 유효성분으로 포함하는 기능성 식품 조성물들은 뛰어난 항산화효과, 활성 산소로부터의 간 보호 효과 및 세포의 스트레스를 감소시키는 효과를 나타낼 수 있다.That is, since the protein hydrolyzate includes a physiologically active peptide, functional food compositions containing it as an active ingredient can exhibit an excellent antioxidative effect, a liver protecting effect from active oxygen, and an effect of reducing cell stress.
상기 기능성 식품 조성물은 여러 가지 영양제, 비타민, 광물(전해질), 합성 풍미제 및 천연 풍미제 등의 풍미제, 착색제 및 중진제(치즈, 초콜릿 등), 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알코올, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있고, 그밖에 천연 과일 주스, 합성 과일 주스 및 야채 음료의 제조를 위한 과육을 더 함유할 수 있다. 이러한 성분은 독립적으로 또는 조합하여 사용될 수 있다.The functional food composition may contain flavors such as various nutrients, vitamins, minerals (electrolytes), synthetic flavors and natural flavors, colorants and heavies (cheese, chocolate, etc.), pectic acid and its salts, alginic acid and its salts, A carbonating agent used in organic acids, protective colloid thickening agents, pH adjusting agents, stabilizers, antiseptics, glycerin, alcohols and carbonated beverages, and the like. May be further contained. These components may be used independently or in combination.
또한, 상기 기능성 식품 조성물은 식품첨가물을 추가로 포함할 수 있으며, "식품첨가물"로서의 적합 여부는 다른 규정이 없는 한 식품의약품 안정청에 승인된 식품첨가물공전의 총칙 및 일반 시험법 등에 따라 해당 품목에 관한 규격 및 기준에 의하여 판정한다.In addition, the functional food composition may further include a food additive, and the suitability of the food additive as a "food additive" is not limited to the corresponding item in the General Rules and General Test Methods approved by the Food and Drug Administration Shall be determined according to the relevant standards and standards.
상기 "식품첨가물공전"에 수재된 품목으로 예를 들어, 케톤류, 글리신, 구연산 칼륨, 니코틴산, 계피산 등의 화학적 합성품, 감색소, 감초추출물, 결정셀룰로오스, 고랭색소, 구아검 등의 천연첨가물, L-글루타민산나트륨 제제, 면류 첨가 알칼리제, 보존 료제제, 타르색소 제제 등의 혼합 제제류 등을 들 수 있다.Examples of the products that have been used in the above-mentioned "food additives" include natural products such as ketones, chemical products such as glycine, potassium citrate, nicotinic acid and cinnamic acid, sensory coloring matter, licorice extract, crystalline cellulose, high- - Mixed preparations such as a sodium glutamate preparation, a noodle-added alkaline agent, a preservative preparation, and a tar coloring agent.
상기 기능성 식품은 육류, 소세지, 빵, 초콜릿, 캔디류, 스넥류, 과자류, 피자, 라면, 껌류, 아이스크림류, 스프, 음료수, 차, 기능수, 드링크제, 알코올 및 비타민 복합제 중 어느 하나의 형태일 수 있으나, 이에 제한되는 것은 아니다.The functional food may be in the form of any one of meat, sausage, bread, chocolate, candy, snack, confectionery, pizza, ramen, gum, ice cream, soup, beverage, tea, functional water, drink, alcohol and vitamin complex , But is not limited thereto.
이때, 기능성 식품을 제조하는 과정에서 식품에 첨가되는 본 발명에 따른 갈색거저리 유충의 단백 가수분해물은 필요에 따라 그 함량을 적절히 가감할 수 있다.At this time, the protein hydrolysates of the larvae of the present invention, which are added to foods in the process of producing the functional food, can be appropriately added or decreased as needed.
더불어, 본 발명은 (a) 기질인 건조된 갈색거저리( Tenebrio molitor , mealworm) 유충의 분말을 물 또는 완충용액에 1 내지 10%(w/v)로 혼합하여 기질 용액을 제조하는 단계; (b) 상기 기질 용액을 가열하여 기질 용액에 포함된 자가 효소를 불활성화하는 단계; (c) 상기 기질 용액에 단백질 가수분해 효소를 갈색거저리 유충 분말 대비 0.1 내지 5%(w/v)가 되도록 혼합하여 혼합액을 제조하는 단계; (d) 상기 혼합액에서 단백질 가수분해 효소와 갈색거저리 유충 분말을 반응시켜 반응 혼합액을 제조하는 단계; (e) 상기 반응 혼합액을 가열함으로써 단백질 가수분해 효소를 불활성화시켜 반응이 완료된 혼합액을 얻는 단계; (f) 상기 단계 (e)에서 얻어진 혼합액을 원심분리하여 상등액을 취하는 단계; (g) 상기 상등액을 여과막을 이용하여 원심분리하는 단계; 및 (h) 중량 평균 분자량이 0.01 kDa 이상 3 kDa 이하인 단백 가수분해물을 분리하는 단계;를 포함하는 갈색거저리 유충의 단백 가수분해물 제조방법을 제공한다. 상기와 같은 방법으로 갈색거저리 유충의 단백 가수분해물을 제조할 때, 가장 높은 수율의 생리활성 펩타이드를 얻을 수 있으므로 바람직하다.In addition, the present invention relates to a process for the preparation of (a) a dried brown gill ( Tenebrio molitor , mealworm) 1 to 10% (w / v) of the larval powder in water or buffer solution to prepare a substrate solution; (b) heating the substrate solution to inactivate the self-enzyme contained in the substrate solution; (c) mixing the substrate solution with a protein hydrolyzing enzyme in an amount of 0.1 to 5% (w / v) relative to the brown goat larvae powder to prepare a mixture; (d) preparing a reaction mixture by reacting a protein hydrolyzing enzyme and a brown larvae larva in the mixture; (e) heating the reaction mixture to inactivate the protein hydrolyzing enzyme to obtain a reaction mixture; (f) centrifuging the mixed solution obtained in step (e) to take a supernatant; (g) centrifuging the supernatant using a filtration membrane; And (h) separating a protein hydrolyzate having a weight average molecular weight of 0.01 kDa or more and 3 kDa or less. When the protein hydrolyzate of brown larvae is prepared by the above-described method, the physiologically active peptide with the highest yield can be obtained.
이때, 바람직하게는 상기 단계 (a)에서 건조된 갈색거저리 유충의 분말을 물 또는 완충용액에 3 내지 7%(w/v)로 혼합하여 기질 용액을 제조할 수 있고, 보다 바람직하게는 4%(w/v)로 혼합하여 기질 용액을 제조할 수 있다.At this time, the substrate solution may be prepared by mixing the brown germ larva powder dried in step (a) with water or a buffer solution at 3 to 7% (w / v), more preferably 4% (w / v) to prepare a substrate solution.
상기 완충용액은 바람직하게는 인산 나트륨 버퍼일 수 있다.The buffer solution may preferably be a sodium phosphate buffer.
또한, 바람직하게는 상기 단계 (c)에서 단백질 가수 분해효소를 상기 갈색거저리 유충 분말 대비 0.5 내지 3%(w/v)가 되도록 혼합하여 혼합액을 제조할 수 있고, 보다 바람직하게는 1%(w/v)로 혼합하여 혼합액을 제조할 수 있다.Preferably, in step (c), the protein hydrolyzing enzyme may be mixed with the brown goat larva powder at a concentration of 0.5 to 3% (w / v), more preferably 1% (w / v) to prepare a mixed solution.
더욱이, 상기 단계 (b) 또는 단계 (e)에서 상기 반응 혼합액을 60℃ 내지 100℃에서 가열함으로써 자가 효소 또는 단백질 가수분해 효소를 불활성화시킬 수 있고, 바람직하게는 75℃ 내지 95℃, 보다 바람직하게는 90℃에서 가열함으로써 자가 효소 또는 단백질 가수분해 효소를 불활성화시킬 수 있다.Further, in the step (b) or (e), the reaction mixture may be heated at 60 ° C to 100 ° C to inactivate the self-enzyme or the protein hydrolase, preferably 75 ° C to 95 ° C, more preferably , It is possible to inactivate the self-enzyme or the protein hydrolase by heating at 90 ° C.
상기 단백질 가수분해 효소는 알칼라아제(Alcalase)일 수 있다.The protein hydrolyzing enzyme may be an Alcalase.
또는, 상기 단백질 가수분해 효소는 알칼라아제(Alcalase)와 플라보르자임(Flavourzyme), 뉴트라아제(Neutrase), 펩신(Pepsin), 서브틸리신(Subtilisin) 및 판크레아틴(Pancreatin)으로 이루어진 군에서 선택된 어느 하나 이상일 수 있으나, 이에 제한되는 것은 아니다.Alternatively, the protein hydrolase is selected from the group consisting of Alcalase and Flavourzyme, Neutrase, Pepsin, Subtilisin and Pancreatin. But the present invention is not limited thereto.
즉, 본 발명에 따른 갈색거저리 유충의 단백 가수분해물, 이의 제조방법 및 이를 포함하는 기능성 식품 조성물은 특정한 종류의 단백질 가수분해 효소를 사용함으로써 항산화 효과를 나타내는 생리활성 펩타이드의 수율을 높이고, 이를 유용하게 활용할 수 있다.In other words, the protein hydrolyzate of brown larch larva according to the present invention, the method for producing the protein hydrolyzate, and the functional food composition containing the protein hydrolyzate according to the present invention can increase the yield of the physiologically active peptide showing an antioxidative effect by using a specific type of protein hydrolyzing enzyme, Can be utilized.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이며 본 발명의 내용을 예시하는 것일 뿐이므로 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다.BEST MODE FOR CARRYING OUT THE INVENTION Hereinafter, the present invention will be described in detail with reference to the following examples. It is to be understood that both the foregoing description and the following detailed description are exemplary and explanatory and are intended to provide further explanation of the invention as claimed. no.
<준비예 1> 시료의 준비<Preparation Example 1> Preparation of sample
실험을 위해, 2016년 3월 18일에 농업법인회사 (주)MG내츄럴(전남 담양군 무정면)에서 생산, 판매된 것으로, 진공건조된 갈색거저리의 유충을 구입하여 동결고에 보관하였고 실험에 사용하였다.For the experiment, it was produced and sold on March 18, 2016 by MG Natural Co., Ltd. (Mudung-myeon, Damyang-gun, Jeollanam-do). The larvae of vacuum-dried brown duck were purchased and stored in frozen ware .
또한, 모든 실험 데이터는 최소 3번 반복하여 평균과 표준오차(평균±표준오차)로 나타내었으며, 통계 분석을 위해 SPSS Statistics 23(Version 23.0, Inc, Chicago, IL, USA)가 사용되었다. 그룹 간의 유의성 차이 검증에는 일원 배치 분산 분석(One-way ANOVA)을 사용하였으며, Scheffe의 다중 범위 검정 방법을 통한 사후 검증을 시행하였다. 유의 확률(P-value)이 0.05 미만인 경우 통계적으로 유의한 것으로 판단하였다.In addition, all the experimental data were expressed as mean and standard error (mean ± standard error) at least 3 times and SPSS Statistics 23 (Version 23.0, Inc, Chicago, IL, USA) was used for statistical analysis. One-way ANOVA was used to verify the significance of differences between groups, and post-test was performed using Scheffe's multiple range test. If the significance (P-value) was less than 0.05, it was judged to be statistically significant.
<실시예 1> 갈색거저리 유충 단백질 가수분해물의 제조Example 1 Preparation of Protein Hydrolyzate of Brown Goat Protein
도 1에 나타난 바와 같이, 상기 준비예 1에서 준비한 동결 건조된 갈색거저리 유충 분말을 10 mM 인산 나트륨 버퍼(pH 7.0)에 용해하여 4%(w/v)의 기질 용액으로 제조한 후, 90℃에서 20분 동안 자가 효소를 불활성화시켰다. 다음 기질 대비 단백질 가수분해 효소들(알칼라아제(alcalase), 플라보르자임(flavourzyme), 뉴트라아제(neutrase), 브로멜라인(bromelain), 파파인(papain))이 1%(w/v)이 되도록 각 효소들을 처리하고, 각 효소별 최적온도인 55℃에서 24시간 반응시켰다. 이때, 각 펩타이드들을 대상으로 TNBS 및 SDS-전기영동을 수행하기 위해 시간별로 반응혼합액 5 mL씩 채취하였다. 24시간 이후, 최종 반응혼합액을 90℃에서 20분간 가열시켜 효소를 불활성화시켰다. 그 후 반응액을 13,000 xg에서 20분 동안 원심분리하여 상등액을 얻었으며, 상등액을 추가적으로 한외여과막을 이용하여 2시간 동안 원심분리(5,000 xg)함으로써 최종적으로 분자량 3 kDa 이하의 단백 가수분해물을 얻었다. 이렇게 얻어진 단백 가수분해물은 동결건조한 후 20℃에 보관하면서 실험에 사용되었다.As shown in FIG. 1, the lyophilized brown gill larva powder prepared in Preparation Example 1 was dissolved in 10 mM sodium phosphate buffer (pH 7.0) to prepare a 4% (w / v) substrate solution. Lt; / RTI > for 20 minutes. 1% (w / v) of protein hydrolytic enzymes (alcalase, flavourzyme, neutrase, bromelain, papain) Each enzyme was treated and reacted at 55 ℃ for 24 hours. At this time, each of the peptides was sampled by 5 mL of reaction mixture every hour to perform TNBS and SDS-electrophoresis. After 24 hours, the final reaction mixture was heated at 90 DEG C for 20 minutes to inactivate the enzyme. Then, the reaction solution was centrifuged at 13,000 × g for 20 minutes to obtain a supernatant. The supernatant was further centrifuged (5,000 × g) for 2 hours using an ultrafiltration membrane to obtain a protein hydrolyzate having a molecular weight of 3 kDa or less. The protein hydrolysates were lyophilized and stored at 20 ° C.
<실시예 2> 갈색거저리 유충 단백질 가수분해물의 물리적 특성 확인Example 2: Identification of physical properties of the larval protein hydrolyzate
(1) 나트륨 (1) Sodium 도데실Dodecyl 설폰산염Sulfonate 폴리아크릴아미드Polyacrylamide 겔 전기이동(Sodium Gel electrophoresis dodecylsulfatedodecylsulfate polyacrylamide폴리acrylamide gel electrophoresis, SDS-PAGE) gel electrophoresis, SDS-PAGE)
단백질 가수분해효소 종류에 따른 갈색거저리 유충의 펩타이드를 확인하기 위해, 단백질의 SDS-PAGE 패턴을 측정하여 각각의 가수분해물에서 나타난 단백질의 분해 패턴을 조사하였다. SDS-PAGE은 Laemmli(Laemmli, UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. nature 227: 680-685.)의 방법으로 실시하였으며, 사용된 분리 겔은 15%를 사용하였고, 가수분해된 단백질에서 12000 rpm, 4℃, 10분 원심분리 후 상등액 20 ㎕을 겔에 로딩하여 80V에서 약 2시간 전기 영동하였다. 이후, 쿠마시 브릴리언트 블루(coomassie brilliant blue)를 사용하여 밴드들을 염색하고 10% 아세트산이 함유된 30% 메탄올을 이용하여 탈색하였다. 대조군으로는 효소를 처리하지 않은 기질 용액을 사용하였고, 단백질 패턴의 분석은 Gel Logic 2200 PRO를 이용하여 폴리아크릴아미드 겔을 스캐닝한 후 이미지로 영상화시켜 수행하였다. 이때, 분자량 마커(molecular weight marker)는 BIO-RAD(Bio-Rad Laboratories, CA, USA)의 제품을 이용하였다.In order to identify peptides of brown larvae according to protein hydrolytic enzymes, SDS-PAGE patterns of proteins were measured and the degradation patterns of the proteins in the respective hydrolysates were examined. SDS-PAGE was carried out using Laemmli (Laemmli, UK, 1970. Cleavage of structural proteins during the assembly of the bacteriophage T4, nature 227: 680-685), 15% , Hydrolyzed proteins were centrifuged at 12,000 rpm at 4 ° C for 10 minutes, and 20 μl of the supernatant was loaded on the gel and electrophoresed at 80 V for about 2 hours. The bands were then stained using coomassie brilliant blue and decolorized with 30% methanol containing 10% acetic acid. As a control, an enzyme-free substrate solution was used. Protein pattern analysis was performed by scanning the polyacrylamide gel using Gel Logic 2200 PRO and imaging the image. At this time, a molecular weight marker was obtained from BIO-RAD (Bio-Rad Laboratories, CA, USA).
그 결과, 도 2에 나타난 바와 같이, 효소를 처리하지 않은 대조군(도 2의 [6])에 비해 알칼라아제 단백 가수분해물의 경우(도 2의 [1]), 크기가 10 kDa 이상인 것들은 모두 분해되어 이 크기의 밴드들은 나타나지 않았다. 이로부터 알칼라아제를 처리한 용액에 저분자 펩타이드가 많으며, 알칼라아제의 가수분해도가 우수함을 확인하였다. 뉴트라아제(도 2의 [4])는 알칼라아제를 이용한 단백 가수분해물보다 10 kDa 이상의 밴드가 뚜렷하였다. 플라보르자임(도 2의 [3])은 알칼라아제, 뉴트라아제 단백 가수분해물보다 밴드의 수가 증가하여 큰 분자량의 펩타이드가 보였다. 반면 브로멜라인(도 2의 [2]) 및 파파인(도 2의 [5]) 단백 가수분해물에서는 10 kDa - 25 kDa 사이의 단백질 띠가 선명하여, 이 분자량 크기의 펩타이드를 많이 함유한 것을 확인할 수 있었다.As a result, as shown in Fig. 2, in the case of the hydrolyzate of the alkaline protease ([1] in Fig. 2) compared with the control group not treated with the enzyme The bands of this size did not appear to be degraded. From this, it was confirmed that the solution treated with the alkalase had many low molecular peptides, and the hydrolysis degree of the alkalase was excellent. Nutraaze ([2] in Fig. 2) showed a band of more than 10 kDa than protein hydrolyzate using alkalase. Plaborozymes ([3] in Fig. 2) showed peptides with large molecular weights due to an increase in the number of bands as compared with hydrolysates of alkalase and Ntrease. On the other hand, protein hydrolysates of bromelain ([2] in Fig. 2) and papain (in Fig. 2 [5]) show clear protein bands of 10 kDa to 25 kDa and confirm that they contain a large number of peptides of this molecular size I could.
이러한 SDS-PAGE 결과를 종합해 보았을 때, 효소별 단백 가수분해물 중 알칼라아제, 뉴트라아제, 플라보르자임, 브로멜라인, 파파인의 순서로 가수분해물에서 저분자 펩타이드가 많이 함유된 것을 알 수 있었다. When SDS-PAGE results are summarized, it was found that the hydrolysates of the enzyme hydrolyzate contain a large amount of low molecular weight peptides in the order of alkalase, ntrease, flavorzyme, bromelain and papain.
(2) 가수분해물의 수율 측정(2) Measurement of yield of hydrolyzate
상기 실시예 1에서 효소를 이용해 갈색거저리 유충의 단백질 가수분해물을 제조하기 위해 최적 분해 조건하에서 24시간까지 효소 분해를 실시하였다. 즉, pH 7.0의 완충용액을 혼합한 갈색거저리 유충 시료와 알칼라아제, 플라보르자임, 뉴트라아제, 브로멜라인, 파파인을 첨가하여 24시간 효소 분해하였고, 효소를 불활성화 하기 위해 100℃에서 20분간 반응시켜 이를 원심 분리기를 이용해 상등액을 채취하였으며, 8℃의 5,000 xg, 2시간 한외여과막을 이용하여 3 kDa 이하의 펩타이드들을 분리하였다. 그 후, 동결건조하여 갈색거저리 유충 단백질의 가수분해물을 제조하였는 바, 10 mM 인산 나트륨 버퍼에 의한 염을 고려하여 하기 식 1에 나타난 바와 같이 갈색거저리 유충 단백질의 가수분해물을 갈색거저리 고형분에 대한 비로 나타내어, 가수분해물의 수율을 계산하였다.The enzymatic degradation was carried out for 24 hours under optimal decomposition conditions in order to prepare the protein hydrolyzate of brown larvae using the enzyme in Example 1 above. Namely, a brown goat larva sample mixed with a buffer solution of pH 7.0, and alkalase, flavozyme, ntrease, bromelain and papain were added for 24 hours to inactivate the enzyme. To inactivate the enzyme, . The supernatant was collected by centrifugation, and peptides of 3 kDa or less were isolated using an ultrafiltration membrane at 5,000 xg for 2 hours at 8 ° C. Thereafter, the hydrolyzate of the brown larch larvae protein was prepared by lyophilization. As shown in the
[식 1][Formula 1]
그 결과, 도 3에 나타난 바와 같이, 알칼라아제를 첨가한 단백 가수분해물의 수율이 44.71%로 가장 높았으며, 뉴트라아제 34.33%, 플라보르자임 23.17%, 브로멜라인 15.75%, 파파인 11.82% 순으로 나타났다. 이는 알칼라아제를 처리한 단백 가수분해물의 3 kDa 이하 펩타이드의 수율을 확인한 SDS-PAGE 실험 결과와 일치하는 것이다. 따라서 수율이 높은 알칼라아제, 플라보르자임, 뉴트라아제 효소를 처리한 단백 가수분해물을 경제적, 생산적으로 유용하게 사용할 수 있다.As a result, as shown in Fig. 3, the yield of protein hydrolyzate with alkalase was the highest at 44.71%, and that of Nutrase was 34.33%, flavorzyme 23.17%, bromelain 15.75%, papain 11.82% Respectively. This is in agreement with the result of SDS-PAGE analysis of the yield of the 3 kDa peptide of the protein hydrolyzate treated with the alkalase. Therefore, protein hydrolysates obtained by treating enzymes of higher yields such as alkalase, flavorzyme and Ntrease can be used economically and productively.
(3) 단백질의 가수분해도 측정(3) Measurement of hydrolysis degree of protein
상기 효소들에 의해 얼마만큼의 단백질이 가수분해되는지를 확인하기 위해, 트리니트로벤젠설폰산(Trinitrobenzenesulfonic acid, TNBS) 방법(G-Biosciences Co.)을 이용하여 시간에 따른 갈색거저리 유충 단백 가수분해물에서 펩타이드의 함량을 측정하였다. 단백질이 가수분해되면 가수분해도에 비례하여 유효성 아미노기의 농도가 증가하는 원리를 이용하였다.In order to confirm how much of the protein is hydrolyzed by the enzymes, the protein was hydrolyzed with a peptide of Tricholobenzenesulfonic acid (TNBS) method (G-Biosciences Co.) Was measured. When the protein is hydrolyzed, the concentration of the effective amino group increases in proportion to the degree of hydrolysis.
구체적으로, 상기 실시예 1과 같이 세 종류의 효소 및 기질 혼합액을 제조한 후 0, 0.5, 1, 2, 4, 6, 8, 12 및 24시간마다 시간에 따른 갈색거저리 유충 단백질의 가수분해도를 측정하였다. 10 mM 중탄산나트륨(sodium bicarbonate; pH 8.5) 990 ㎕와 1% TNBS 10 ㎕를 혼합(v/v)하여 0.01% TNBS를 제조하고, TNBS 50 ㎕와 시간별로 취한 반응혼합액 100 ㎕를 섞어 37℃에서 2시간 반응시킨 후 반응을 정지시키기 위해 10% 도데실 황산나트륨(sodium dodecylsulfate; 10% SDS)과 1N 염화수소(hydrogen chloride; 1N HCl)를 첨가하였다. 그리고 마이크로플레이트 분광 광도계(microplate spectrophotometer)를 이용하여 335 nm에서 각 혼합액들의 흡광도를 측정하였다. 이후 이 결과를 타이로신 함량으로 환산하였다.Specifically, the hydrolysis degree of the larval larvae protein over time at 0, 0.5, 1, 2, 4, 6, 8, 12 and 24 hours after preparing three kinds of enzyme and substrate mixtures as in Example 1 Respectively. 0.01% TNBS was prepared by mixing 990 μl of 10 mM sodium bicarbonate (pH 8.5) and 10 μl of 1% TNBS, and 50 μl of TNBS and 100 μl of the reaction mixture taken over time were mixed and incubated at 37 ° C After the reaction for 2 hours, 10% sodium dodecylsulfate (10% SDS) and 1N hydrogen chloride (1N HCl) were added to stop the reaction. The absorbance of each mixture was measured at 335 nm using a microplate spectrophotometer. The results were then converted to tyrosine content.
그 결과, 도 4에 나타난 바와 같이, 플라보르자임 5429.35 ㎍/mL, 알칼라아제 4781.38 ㎍/mL, 뉴트라아제 3155.55 ㎍/mL, 브로멜라인 1800.00 ㎍/mL, 파파인 1782.61 ㎍/mL 순으로 나타났다. 이는 SDS-PAGE 및 수율 측정결과와 유사한 결과이다.As a result, as shown in Fig. 4, flavorzyme 5429.35 / / mL, alcalase 4781.38 / / mL, neutraze 3155.55 / / mL, bromelain 1800.00 / / mL and papain 1782.61 / / mL. This is similar to the result of SDS-PAGE and yield measurement.
이후, 가수분해도가 우수하였던 알칼라아제, 플라보르자임 및 뉴트라아제 단백 가수분해물을 이용하여 항산화 활성을 조사하였다.Then, the antioxidative activities were investigated using the hydrolysates of alcalase, flavozyme and ntrease, which had excellent hydrolysis degree.
<실시예 3> 획득한 펩타이드들의 항산화 활성 측정<Example 3> Measurement of antioxidative activity of the obtained peptides
1) DPPH 라디칼 소거활성 측정1) Measurement of DPPH radical scavenging activity
DPPH 라디칼은 항산화 물질이 수소 원자나 전자를 공여할 수 있는 능력을 평가할 때 사용되는 물질로서 수소 혹은 전자를 받음으로써 안정한 형태의 화합물로 전환되어 라디칼 특유의 보라색이 옅은 노란색으로 변한다. 이러한 원리를 이용하여, 단백 가수분해물의 α,α-디페닐-β-피크릴히드라질(α,α-diphenyl-ß-picryhydrazyl, DPPH)에 대한 환원력을 측정함으로써 DPPH 자유 라디칼 소거 활성을 확인하였다.The DPPH radical is a substance used to evaluate the ability of an antioxidant to donate a hydrogen atom or electron, and is converted to a stable form of the compound by receiving hydrogen or electrons, and the radical-specific violet turns into a pale yellow. Using this principle, the DPPH free radical scavenging activity was confirmed by measuring the reducing power of the protein hydrolysates against α, α-diphenyl-β-picryl hydrazine (α, diphenyl-ß-picryhydrazyl, DPPH) .
구체적으로, 99% 메탄올을 이용하여 상기 실시예 1에서 얻은 단백 가수분해물 시료들을 0, 100, 250, 500 또는 1000 ㎍/mL으로 희석하고, 희석된 각 시료들을 96 웰 플레이트에 160 ㎕씩 분주하였다. 그 다음, 메탄올에 녹인 0.2 mM DPPH 용액 40 ㎕를 시료가 분주된 웰에 분주하여 실온에 30분간 방치한 후, 마이크로플레이트 분광광도계를 이용하여 517 nm에서 흡광도를 측정하였다. 그리고 하기 [식 2]를 이용하여 각각의 효소별 갈색거저리 유충 단백 가수분해물의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도인 RC50값으로 나타내었다. 이때 활성 비교를 위하여 양성대조군으로서 트롤록스(Trolox)를 사용하였다.Specifically, the protein hydrolyzate samples obtained in Example 1 were diluted to 0, 100, 250, 500 or 1000 μg / mL using 99% methanol, and 160 μl of the diluted samples were dispensed into 96-well plates . Subsequently, 40 μl of a 0.2 mM DPPH solution dissolved in methanol was dispensed into wells in which the sample was placed, and left at room temperature for 30 minutes. Then, the absorbance was measured at 517 nm using a microplate spectrophotometer. And the RC 50 value, which is the concentration of the sample required to reduce the absorbance of the gelatinous larval protein hydrolyzate of each enzyme by ½ by using [Equation 2] below. Trolox was used as a positive control for activity comparison.
[식 2][Formula 2]
그 결과, 도 5에 나타난 바와 같이, 알칼라아제 단백 가수분해물의 RC50값은 339.34 ㎍/mL, 플라보르자임은 379.35 ㎍/mL, 뉴트라아제는 398.93 ㎍/mL로 나타나 알칼라아제 단백 가수분해물의 DPPH 라디칼 소거활성이 가장 높았다.As a result, as shown in FIG. 5, the RC 50 value of the alkaline protease hydrolyzate was 339.34 / / mL, the flavorzyme 379.35 / / mL, and the neutraceutical 398.93 / / mL, DPPH radical scavenging activity was the highest.
Yoon 등(2007. Antioxidant activity and physiological function of the Anomala albopilosa extracts. Journal of the Korean Society of Food Science and Nutrition 36(6): 670-677.)의 연구 결과와 비교해보면, 청동풍뎅이 유충의 에탄올 추출물의 RC50 값이 483.39 ㎍/mL로 나타나 갈색거저리 유충 단백 가수분해물의 DPPH 라디칼 소거활성이 훨씬 우수한 것을 알 수 있었다.Compared with the results of the study of the antioxidant activity and the physiological function of the Anomala albopilosa extracts, Journal of Food Science and Nutrition 36 (6): 670-677), the ethanol extract of bronze beetle larvae The RC 50 value was 483.39 ㎍ / mL, indicating that the DPPH radical scavenging activity of the brown duck protein hydrolyzate was much better.
또한, Yu 등(2008. 번데기 가수분해물의 ACE 저해활성과 항산화활성. 한국식품영양과학회지 37(2): 136-140.)이 누에 번데기에 뉴트라아제, 알칼라아제, 트립신 및 펩신을 처리하여 단백 가수분해물의 DPPH 라디칼 소거활성을 확인한 결과, 알칼라아제 단백 가수분해물의 RC50값이 396.09 ㎍/mL, 뉴트라아제가 352.75 ㎍/mL, 트립신이 677.44 ㎍/mL, 펩신이 626.09 ㎍/mL으로 나타났다. 즉, 이 결과에서 알칼라아제 및 뉴트라아제의 결과는 갈색거저리 유충 단백 가수분해물과 유사한 경향을 보였고 트립신 및 펩신의 경우 소거활성이 다소 낮은 경향을 보였다.In addition, Yu et al. (2008. ACE inhibitory activity and antioxidative activity of hydrolyzate of pupa), Korean Journal of Food Science and Nutrition 37 (2): 136-140.) This nutrient pupa was treated with Ntase, Alcalase, Trypsin and pepsin checking the DPPH radical scavenging activity of the protein hydrolysates result, the RC 50 value of Alcala kinase protein hydrolyzate with 396.09 ㎍ / mL, Nutra azepin the 352.75 ㎍ / mL, trypsin is 677.44 ㎍ / mL, pepsin is 626.09 ㎍ / mL appear. In other words, the results of alkalase and ntrease showed similar tendency to that of brown duck larvae protein hydrolyzate, and trypsin and pepsin showed slightly lower scavenging activity.
2) ABTS 라디칼 소거활성 측정2) Measurement of ABTS radical scavenging activity
ABTS 라디칼 소거활성 측정법은 표준물질인 트롤록스의 값과 비교하여 나타낼 수 있으며, in vivo에서의 항산화능 측정뿐만 아니라 in vitro에서 항산화능을 측정하기 위한 방법으로 널리 이용되고 있다. ABTS와 과황화칼륨(potassium persulfate)을 암소에 방치하면 ABTS 라디칼이 생성되며, 시료 속 항산화물질로 인해 라디칼이 소거되면 짙은 청록색의 ABTS 라디칼이 탈색되는데 이를 흡광도로 측정하는 방법이다.The ABTS radical scavenging activity assay can be compared with the value of Trolox, which is a standard substance, and it is widely used as a method for measuring antioxidant activity in vitro as well as measuring antioxidant activity in vivo. When ABTS and potassium persulfate are placed in a dark place, ABTS radicals are produced. When the radicals are cleared by antioxidants in the sample, dark cyan ABTS radicals are discolored, which is measured by absorbance.
구체적으로, 최종 농도가 7 mM인 ABTS와 2.45 mM 과황화칼륨을 각각 혼합한 후 실온인 암소에서 24시간 동안 방치하여 라디칼을 형성시켰다. 이후, ABTS 용액의 농도가 734 nm에서 흡광도 값이 0.70±0.02가 되도록 인산 완충 생리 식염수(PBS, pH 7.4)로 희석하였다. 희석된 ABTS 용액 180 ㎕에 각 효소별 단백 가수분해물 20 ㎕를 가하여 1분 동안 30℃에 방치한 후 734 nm에서 흡광도를 측정하였다. 그리고 하기 [식 3]을 이용하여 이렇게 측정된 각각의 효소별 갈색거저리 유충 단백 가수분해물의 흡광도를 1/2로 환원시키는데 필요한 시료의 농도인 RC50값으로 나타내었다. 이때 활성비교를 위하여 양성대조군으로서 트롤록스를 사용하였다.Specifically, ABTS, which was 7 mM in final concentration, 2.45 mM and potassium sulfide were mixed, respectively, and then left in a dark room for 24 hours to form radicals. Then, the concentration of the ABTS solution was diluted with phosphate buffered saline (PBS, pH 7.4) such that the absorbance value was 0.70 ± 0.02 at 734 nm. 20 μl of each protein hydrolyzate was added to 180 μl of the diluted ABTS solution, and the mixture was allowed to stand at 30 ° C for 1 minute and absorbance was measured at 734 nm. And the RC 50 value, which is the concentration of the sample required to reduce the absorbance of the hydrolyzate of the larvae of the larvae of each of the enzymes, measured in accordance with the following
[식 3][Formula 3]
그 결과, 도 6에 나타난 바와 같이, 뉴트라아제 처리를 통해 얻은 단백가수분해물의 RC50은 29.84 ㎍/mL, 알칼라아제는 31.71 ㎍/mL, 플라보르자임은 56.03 ㎍/mL순으로 뉴트라아제 단백 가수분해물의 라디칼 소거 활성이 가장 높은 것을 확인할 수 있었다. As a result, as shown in FIG. 6, the protein hydrolyzate obtained through the treatment with Ntrease was found to have an RC 50 of 29.84 / / mL, an alkalase of 31.71 / / mL and a flavozyme of 56.03 / / It was confirmed that the radical scavenging activity of the hydrolyzate was the highest.
이러한 결과를 Lee 등(2008. 아보카도 추출물의 Apoptosis 유도와 항산화 활성. 한국식품영양과학회지 37(3): 269-275.)의 연구에 따른 아보카도의 80% 메탄올 추출물을 이용하여 ABTS 라디칼 소거활성과 비교해본 결과, 아보카도의 과육은 200 ㎍/mL에서 38.4%로 나타났고, 본 연구에서 사용한 갈색거저리 유충 알칼라아제 단백 가수분해물은 50 ㎍/mL에서 69.80%, 플라보르자임은 49.38% 및 뉴트라아제는 71.41%로, ABTS 라디칼 소거 활성능이 훨씬 우수한 것으로 나타났다.The results of this study are summarized as follows. Lee et al. (2008. Apoptosis induction and antioxidative activity of avocado extract, Korean Journal of Food Science and Nutrition 37 (3): 269-275) As a result of comparison, the flesh of avocado was 38.4% at 200 ㎍ / mL, and the hydrolysates of brown algae protein in this study were 69.80% at 50 ㎍ / mL, 49.38% for flavozyme, Was 71.41%, indicating that the ABTS radical scavenging performance was much better.
3) 과산화수소(Hydrogen peroxide, H3) Hydrogen peroxide, H 22 OO 22 ) 소거활성 측정) Measurement of scavenging activity
산소의 환원 대사물질인 과산화수소(hydrogen peroxide, H2O2)는 다양한 외부요소에 자극받아 정상세포의 미토콘드리아와 퍼록시좀에서 형성되는데, DNA 및 단백질 손상을 유발하거나 불포화지방산과 같은 생체막의 구성성분을 공격하여 과산화지질을 생성함으로써 생체 기능의 저하나 노화 및 성인병을 유발하는 것으로 알려져 있다. 본 발명에서는 퍼록시다아제의 기질인 ABTS를 이용하여 갈색거저리 유충 단백 가수분해물의 H2O2 소거활성을 측정하였다. 구체적으로, Muller HE 등(1985. Detection of hydrogen peroxide produced by microorganisms on an ABTS peroxidase medium. Zentralblatt fur Bakteriologie , Mikrobiologie und Hygiene. Series A: Medical Microbiology, Infectious Diseases, Virology, Parasitology 259(2): 151-154.)의 방법에 따라 증류수에 농도별로 희석한 각 효소별 단백 가수분해물을 20 ㎕, PBS 100 ㎕, 1 mM H2O2 20 ㎕를 96 웰 플레이트에 가한 후 37℃ 인큐베이터에서 5분간 반응시켰다. 이후, 1.25 mM ABTS 30 ㎕와 1 U/mL 퍼록시다아제 30 ㎕를 가하고 37℃에서 10분간 반응시킨 후, 마이크로플레이트 분광 광도계를 이용하여 405 nm에서 흡광도를 측정하였다. 이때 활성비교를 위하여 양성대조군으로서 트롤록스를 사용하였다.Hydrogen peroxide (H 2 O 2 ), a reducing metabolite of oxygen, is formed in the mitochondria and peroxisomes of normal cells stimulated by various external factors. It induces DNA and protein damage or is a component of biomembranes such as unsaturated fatty acids To produce lipid peroxides, which are known to induce hypogonadism, aging and adult diseases. In the present invention, the H 2 O 2 scavenging activity of the brownish larva larvae hydrolyzate was measured using ABTS, a substrate of peroxidase. Specifically, such as HE Muller (1985. Detection of hydrogen peroxide produced by microorganisms on an ABTS peroxidase medium Zentralblatt fur Bakteriologie, Mikrobiologie und Hygiene Series A:.. Medical Microbiology, Infectious Diseases, Virology, Parasitology 259 (2): 151-154 ), 20 μl of each protein hydrolyzate diluted by concentration in distilled water, 100 μl of PBS, and 20 μl of 1 mM H 2 O 2 were added to a 96-well plate, followed by reaction at 37 ° C for 5 minutes in an incubator. Subsequently, 30 μl of 1.25 mM ABTS and 30 μl of 1 U / ml peroxidase were added, reacted at 37 ° C. for 10 minutes, and the absorbance was measured at 405 nm using a microplate spectrophotometer. At this time, Trolox was used as a positive control for the activity comparison.
그 결과, 도 7에 나타난 바와 같이, 알칼라아제 단백 가수분해물의 RC50값은 65.94 ㎍/mL였으며, 뉴트라아제 121.67 ㎍/mL 및 플라보르자임 70.38 ㎍/mL로 나타났다. 이러한 결과를 지금까지 수행된 연구 결과와 비교해보면, Hwang 등(2014. 건조방법에 따른 아로니아(Aronia melancocarpa) 열수 추출물의 항산화 성분 함량 및 항산화 활성. 한국식품과학회지 46(3): 303-308.)은 아로니아 추출물의 H2O2 소거능을 RC50값으로 나타낸 결과 172.05 ㎍/mL로 개재하고 있는 바, 천연물인 아로니아 추출물보다 갈색거저리 유충 단백 가수분해물의 H2O2 소거능이 우수한 것으로 나타났다.As a result, as shown in Fig. 7, the RC 50 value of the hydrolyzed alkaline protease was 65.94 / / mL, 121.67 / / mL of Ntase and 70.38 / / mL of flavozyme. Comparing these results with studies carried out so far, Hwang et al. (Chokeberry (Aronia melancocarpa) antioxidant content and antioxidant activity of hot-water extract of the Journal of the Korea Food and 2014. drying 46 (3): 0.303 to 308 ) Is the H 2 O 2 The results shown in the scavenging RC 50 value, which is interposed in 172.05 ㎍ / mL bar, showed excellent natural product oh H 2 O 2 scavenging of mealworm larvae protein hydrolyzate than Catalonia extract.
4) 리놀레산(linoleic acid) 산화에 대한 산화 방지 효과 확인4) Confirmation of antioxidative effect on oxidation of linoleic acid
지질산화 초기에 발생하는 과산화물은 염화제일철(ferrous chloride)와 반응하여 빨간색에 가까운 염화제이철(ferric chloride) 색소를 생성하게 되며, 지질의 산화가 계속 진행되면 말론알데하이드(malonaldehyde)와 같은 저분자의 화합물이 생성되는데 이것은 다시 티오바르비툴산(thiobarbituric acid, TBA)와 결합하여 빨간색의 화합물을 형성한다. 따라서 본 실험에서는 불포화지방산인 리놀레산을 기질로 하여 갈색거저리 유충 단백 가수분해물의 산화방지 효과를 평가하였다. The peroxide generated in the early stage of lipid oxidation reacts with ferrous chloride to produce a red ferric chloride dye. When the oxidation of lipid continues, a low-molecular compound such as malonaldehyde Which again binds with thiobarbituric acid (TBA) to form a red compound. Therefore, in this experiment, the antioxidant effect of hydrolysates of brown larch larvae was evaluated using linoleic acid, an unsaturated fatty acid, as a substrate.
구체적으로, 상기 3가지 항산화 실험 중 비교적 항산화 활성이 가장 높았던 알칼라아제 단백 가수분해물을 이용하였다. 먼저 리놀레산 반응기질 용액을 제조하기 위해서 50 mM 인산 나트륨 버퍼(pH 7.0) 2 mL와 2.52% 리놀레산 1 mL, 무수 알코올(absolute alcohol) 1 mL, 각 농도별 알칼라아제 단백 가수분해물 1 mL을 혼합한 후 40℃에서 100 rpm으로 진탕하였다. 이후, 20% 트리클로로아세트산(trichloroacetic acid, TCA; w/v) 100 ㎕, 0.8% TBA 100 ㎕와 리놀레산 반응기질 용액 50 ㎕을 잘 혼합하여 95℃ 이상에서 20분 반응시킨 후, 실온에서 10분간 냉각시키고 3000 rpm에서 15분간 원심 분리하여 180 ㎕의 상등액을 흡광도 532 nm에서 측정하였다. 이러한 과정은 하루 간격으로 총 3번 수행되었고, 활성비교를 위하여 양성대조군으로서 트롤록스를 사용하였다.Specifically, among the three antioxidative tests described above, an alkalase hydrolyzate having the highest antioxidant activity was used. First, 2 mL of 50 mM sodium phosphate buffer (pH 7.0), 1 mL of 2.52% linoleic acid, 1 mL of absolute alcohol, and 1 mL of alkaline protease hydrolyzate at each concentration were mixed to prepare a linoleic acid reaction substrate solution And then shaken at 100 rpm at 40 ° C. Then, 100 μl of 20% trichloroacetic acid (TCA; w / v), 100 μl of 0.8% TBA and 50 μl of a linolenic acid reaction substrate solution were mixed well and reacted at 95 ° C. or higher for 20 minutes. Cooled and centrifuged at 3000 rpm for 15 minutes to measure 180 μl of supernatant at 532 nm absorbance. This procedure was performed three times a day at intervals, and Trolox was used as a positive control for activity comparison.
그 결과, 도 8에 나타난 바와 같이, 시간이 지날수록 음성 대조군(단백 가수분해물을 넣지 않음)의 지질 과산화물이 증가하였으며, 음성 대조군의 3일째 흡광도 값을 100%로 봤을 때, 알칼라아제 단백 가수분해물의 농도가 100, 200, 400 및 800 ㎍/mL로 높아짐에 따라 지질 과산화물의 산화 또한 각각 약 27, 33, 40 및 68%를 나타내며 유의적으로 억제됨을 확인하였다. As a result, as shown in FIG. 8, the lipid peroxides of the negative control group (no protein hydrolysates were not added) increased with time, and when the absorbance value at the third day of the negative control group was taken as 100% Oxidation of lipid peroxide was also significantly inhibited by about 27, 33, 40 and 68%, respectively, as the concentration of the degraded product increased to 100, 200, 400 and 800 ㎍ / mL.
<실시예 4> 활성 산소(ROS, HExample 4 [0064] The active oxygen (ROS, H 22 OO 22 )로부터의 간 세포 보호 효과) ≪ / RTI >
(1) 세포 배양(1) Cell culture
마우스 유래의 정상 간세포인 AML-12 세포는 American Type Culture Collection(Manassas, VA, USA)에서 분양받아 사용하였으며, 분양받은 후 10% 소태아혈청(Fetal Bovine Serum, FBS), 1% 인슐린-트랜스퍼린-셀레늄(insulin-transferrin-selenium; ITS), 1% 항생제(페니실린/스트렙토마이신) 및 덱사메타손(40 ng/mL)을 함유하는 DMEM/F-12 배지를 사용하여 5% CO2, 37℃ 조건에서 배양하였다.AML-12 cells, which were normal mouse hepatocytes, were purchased from the American Type Culture Collection (Manassas, Va., USA) and were inoculated with 10% Fetal Bovine Serum (FBS), 1% insulin- selenium (insulin-transferrin-selenium; ITS ), 1% antibiotics (penicillin / streptomycin), and dexamethasone in 5
(2) 세포생존율 측정(2) Measurement of cell viability
활성산소로 인한 세포독성으로부터 갈색거저리 유충 단백 가수분해물의 간세포 보호효과를 알아보기 위하여, AML-12 세포를 2×104 cells/웰의 밀도로 96-웰 플레이트에 분주하고 24시간 배양 후, 알칼라아제, 플라보르자임 및 뉴트라아제 처리 단백 가수분해물을 각 농도 별로 24시간 처리하였다. 이후 7 mM의 H2O2를 1시간 처리하고, MTT 시약(2.5 mg/mL)을 각 웰에 20 μL씩 첨가하여 3시간 배양한 다음, 상층액을 제거하고 각 웰에 생성된 포르마잔(formazan) 결정을 다이메틸설폭사이드(Dimethyl sulforxide, DMSO)로 용해시켜 550 nm에서 흡광도를 측정하였다. 간세포 보호 효과는 H2O2 무처리군(대조군)의 생존율을 기준으로 각 처리군의 상대적인 세포생존율(cell viability)을 평가하여 계산하였다. AML-12 cells were plated at a density of 2 × 10 4 cells / well in a 96-well plate and incubated for 24 hours. After incubation for 24 hours, The hydrolysates of carrageenan, flavozyme, and ntrease were treated for 24 hours at each concentration. Then, 7 mM H 2 O 2 was treated for 1 hour, and 20 μL of MTT reagent (2.5 mg / mL) was added to each well for 3 hours. Then, the supernatant was removed, and the formazan formazan crystals were dissolved in dimethyl sulfoxide (DMSO) and absorbance was measured at 550 nm. The hepatocyte protective effect was calculated by evaluating the relative cell viability of each treatment group based on the survival rate of the H 2 O 2 -free group (control group).
그 결과, 도 9에 나타난 바와 같이, 7 mM H2O2에 의해 AML-12 세포의 생존율은 21% 정도로 낮아졌으나, 각 단백 가수분해물을 처리한 세포의 경우 세 가지 효소 처리군 모두 유의적인 세포생존율의 증가를 보였다. 특히 그중 알칼라아제 처리 단백 가수분해물은 1, 2.5, 5 mg/mL의 농도에서 각각 53, 68 및 75%의 세포생존율을 보여 활성산소에 의한 세포독성으로부터 간세포를 보호하는 효과가 가장 큰 것으로 나타났다. As a result, as shown in FIG. 9, the survival rate of AML-12 cells was reduced to about 21% by 7 mM H 2 O 2 , but in the case of cells treated with each protein hydrolyzate, The survival rate was increased. Among them, hydrolysates of alkaline protease hydrolysates showed cell survival rates of 53, 68 and 75% at concentrations of 1, 2.5, and 5 mg / mL, respectively, showing the greatest effect of protecting hepatocytes from reactive oxygen species cytotoxicity .
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 즉, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다.While the present invention has been particularly shown and described with reference to specific embodiments thereof, those skilled in the art will appreciate that such specific embodiments are merely preferred embodiments and that the scope of the present invention is not limited thereby. Do. That is, the practical scope of the present invention is defined by the appended claims and their equivalents.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160152535A KR101966503B1 (en) | 2016-11-16 | 2016-11-16 | Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020160152535A KR101966503B1 (en) | 2016-11-16 | 2016-11-16 | Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20180055120A true KR20180055120A (en) | 2018-05-25 |
KR101966503B1 KR101966503B1 (en) | 2019-04-05 |
Family
ID=62299261
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160152535A KR101966503B1 (en) | 2016-11-16 | 2016-11-16 | Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101966503B1 (en) |
Cited By (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200016813A (en) * | 2018-08-07 | 2020-02-17 | 경상남도 | Composition for skin whitening comprising enzymatic hydrolysates of insect |
WO2020091484A1 (en) * | 2018-10-31 | 2020-05-07 | 씨제이제일제당 (주) | Allomyrina dichotoma larva extract and method for preparing same |
KR20200069565A (en) * | 2018-12-07 | 2020-06-17 | 선문대학교 산학협력단 | A composition for improving blood circulation comprising edible insect protein |
KR20200069563A (en) * | 2018-12-07 | 2020-06-17 | 선문대학교 산학협력단 | A composition for anti-obesity comprising defatted mealworm protein-derived peptide |
KR20200098459A (en) * | 2020-08-12 | 2020-08-20 | 계명대학교 산학협력단 | Composition for Improving Wrinkle, Wound Healing, Cosmetic Surgery, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Tenebrio molitor |
KR20200125239A (en) * | 2019-04-26 | 2020-11-04 | 계명대학교 산학협력단 | Peptide isolated from protein hydrolysate of Tenebrio molitor mealworm and composition for preventing or treating liver injury comprising the same |
KR20210058756A (en) * | 2019-11-13 | 2021-05-24 | (재) 순천천연물의약소재개발연구센터 | Composition comprising extracts of fat-removed and fermented tenebrio molitor as an effective ingredient for preventing and treating alcoholic liver disease |
WO2021201507A1 (en) * | 2020-03-30 | 2021-10-07 | 고려대학교 산학협력단 | Composition for preventing, improving, or treating sarcopenia, comprising tenebrio molitor larval protein or hydrolysate thereof as active ingredient |
KR20210122125A (en) * | 2020-03-30 | 2021-10-08 | 고려대학교 산학협력단 | Composition for preventing, improving or treating sarcopenia comprising a mealworm larvae protein or its hydrolysate |
EP4140320A4 (en) * | 2020-04-23 | 2024-05-22 | CJ Cheiljedang Corporation | Bowel movement improving composition comprising allomyrina dichotoma larva extract |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102076459B1 (en) | 2019-10-29 | 2020-02-13 | 주식회사 한미양행 | Composition containing enzyme treatmented Tenebrio molitor for muscle mass enhancement and restorative rejuvenation of recovering patients or elderly patients |
KR102572979B1 (en) | 2020-02-28 | 2023-08-31 | 건국대학교 글로컬산학협력단 | Composition for preventing of treating sarcopenia or muscular dystrophy containing Tenbrio molitor and balloon-flower extract |
KR20220072915A (en) | 2020-11-25 | 2022-06-03 | 한국식품연구원 | A composition for the prevention or treatment of hypertension containing edible insects hydrolysates and fractions thereof |
KR102519704B1 (en) | 2020-12-02 | 2023-04-10 | 이한별 | Vinegar production method using brown goosebumps larva |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101404566B1 (en) | 2012-11-09 | 2014-06-11 | 동아대학교 산학협력단 | Composition for preventing or treating dementia comprising Tenebrio molitor extract |
KR20160041115A (en) * | 2014-10-06 | 2016-04-18 | 대한민국(농촌진흥청장) | Composition for Prevention or Treatment diabetes comprising Tenebrio molitor larva or extract suspension of Tenebrio molitor larva |
-
2016
- 2016-11-16 KR KR1020160152535A patent/KR101966503B1/en active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101404566B1 (en) | 2012-11-09 | 2014-06-11 | 동아대학교 산학협력단 | Composition for preventing or treating dementia comprising Tenebrio molitor extract |
KR20160041115A (en) * | 2014-10-06 | 2016-04-18 | 대한민국(농촌진흥청장) | Composition for Prevention or Treatment diabetes comprising Tenebrio molitor larva or extract suspension of Tenebrio molitor larva |
Non-Patent Citations (2)
Title |
---|
Chunhua Dai 외 3명. Angiotensin I-converting enzyme (ACE) inhibitory peptide derived from Tenebrio molitor(L.) larva protein hydrolysate. Eur Food Res Technol. 236:681-689. (2013.04.)* * |
Chunhua Dai 외 5명. Larva powder of Tenebrio molitor(L.): Enzymatic hydrolysis and antioxidation activity. J. Chinese Cereals and Oils Association (2009.12.)* * |
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20200016813A (en) * | 2018-08-07 | 2020-02-17 | 경상남도 | Composition for skin whitening comprising enzymatic hydrolysates of insect |
WO2020091484A1 (en) * | 2018-10-31 | 2020-05-07 | 씨제이제일제당 (주) | Allomyrina dichotoma larva extract and method for preparing same |
EP3874969A4 (en) * | 2018-10-31 | 2022-08-03 | CJ Cheiljedang Corporation | Allomyrina dichotoma larva extract and method for preparing same |
KR20200069565A (en) * | 2018-12-07 | 2020-06-17 | 선문대학교 산학협력단 | A composition for improving blood circulation comprising edible insect protein |
KR20200069563A (en) * | 2018-12-07 | 2020-06-17 | 선문대학교 산학협력단 | A composition for anti-obesity comprising defatted mealworm protein-derived peptide |
KR20200125239A (en) * | 2019-04-26 | 2020-11-04 | 계명대학교 산학협력단 | Peptide isolated from protein hydrolysate of Tenebrio molitor mealworm and composition for preventing or treating liver injury comprising the same |
WO2020218727A3 (en) * | 2019-04-26 | 2020-12-30 | 계명대학교 산학협력단 | Peptide isolated from protein hydrolysate of tenebrio molitor mealworm and composition comprising same as active ingredient for prevention or treatment of liver injury |
KR20210058756A (en) * | 2019-11-13 | 2021-05-24 | (재) 순천천연물의약소재개발연구센터 | Composition comprising extracts of fat-removed and fermented tenebrio molitor as an effective ingredient for preventing and treating alcoholic liver disease |
WO2021201507A1 (en) * | 2020-03-30 | 2021-10-07 | 고려대학교 산학협력단 | Composition for preventing, improving, or treating sarcopenia, comprising tenebrio molitor larval protein or hydrolysate thereof as active ingredient |
KR20210122125A (en) * | 2020-03-30 | 2021-10-08 | 고려대학교 산학협력단 | Composition for preventing, improving or treating sarcopenia comprising a mealworm larvae protein or its hydrolysate |
EP4140320A4 (en) * | 2020-04-23 | 2024-05-22 | CJ Cheiljedang Corporation | Bowel movement improving composition comprising allomyrina dichotoma larva extract |
KR20200098459A (en) * | 2020-08-12 | 2020-08-20 | 계명대학교 산학협력단 | Composition for Improving Wrinkle, Wound Healing, Cosmetic Surgery, Treating Hair Loss, or Stimulating Hair Growth Comprising Protein Hydrolysate of larva of Tenebrio molitor |
Also Published As
Publication number | Publication date |
---|---|
KR101966503B1 (en) | 2019-04-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101966503B1 (en) | Protein Hydrolysate of larva of Tenebrio molitor, Method for Preparing the Same and Food Comprising the Same | |
Olatunde et al. | Natural preservatives for extending the shelf‐life of seafood: A revisit | |
Sakanaka et al. | Antioxidant properties of casein calcium peptides and their effects on lipid oxidation in beef homogenates | |
Faithong et al. | Chemical composition and antioxidative activity of Thai traditional fermented shrimp and krill products | |
KR101914858B1 (en) | Protein Hydrolysate of larva of Protaetia brevitarsis, Method for Preparing the Same and Composition Comprising the Same | |
Zhong et al. | Antioxidant properties of peptide fractions from silver carp (Hypophthalmichthys molitrix) processing by-product protein hydrolysates evaluated by electron spin resonance spectrometry | |
Ko et al. | Purification and determination of two novel antioxidant peptides from flounder fish (Paralichthys olivaceus) using digestive proteases | |
KR101147847B1 (en) | Method for isolating and purifying functional peptide derived from shellfish and the use of the functional peptide | |
CN103384526A (en) | Oral health improving compositions | |
WO2015050294A1 (en) | Hydrolysate of animal protein, manufacturing method thereof and use thereof | |
JP2008007419A (en) | Hydrolyzed shell membrane produced from shell membrane of hen's egg with proteinase, method for producing the same and functional material added therewith | |
KR101935153B1 (en) | Protein Hydrolysate of larva of Allomyrina dichotoma, Method for Preparing the Same and Composition Comprising the Same | |
Nikoo et al. | Protein hydrolysates derived from aquaculture and marine byproducts through autolytic hydrolysis | |
KR100999429B1 (en) | Yeast hydrolysate which has obesity treatment and antioxidative function | |
Zhang et al. | Antioxidant activities of protein hydrolysates obtained from the housefly larvae | |
Nagai et al. | Antioxidative ability in a linoleic acid oxidation system and scavenging abilities against active oxygen species of enzymatic hydrolysates from pollen Cistus ladaniferus | |
Doungapai et al. | UV-B protective and antioxidant activities of protein hydrolysate from sea cucumber (Holothuria scabra) using enzymatic hydrolysis | |
Kim et al. | Marine Antioxidants: Preparations, Syntheses, and Applications | |
KR20200079215A (en) | Composition for Silkworm-collagen and manufacturing method thereof | |
KR20180010067A (en) | Hydrolysate of mealworm for anti-oxidant | |
KR102581772B1 (en) | A method of optimal cultivation for preparing cultured meat using plant and insect protein hydrolysate and application of the same | |
KR101920117B1 (en) | Manufacturing method of oyster hydrolysate and peptides purified from oyster hydrolysate | |
Araiza-Calahorra et al. | Proteins, peptides, and protein hydrolysates as immunomodulatory and antioxidant agents for the formulation of functional foods | |
KR101918692B1 (en) | Flounder surimi with anti-oxidant effect and manufacturing method thereof | |
Park | Antioxidant Activities of Casein Hydrolysate Fractions with Different Isoelectric Points in Food System |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
E601 | Decision to refuse application | ||
AMND | Amendment | ||
E902 | Notification of reason for refusal | ||
AMND | Amendment | ||
X701 | Decision to grant (after re-examination) | ||
GRNT | Written decision to grant |